Being in the office is more important for some employees, like bankers working on an IPO, and less important for others, like advisers working with wealthy clients, bank’s COO says
Most offices will reopen in the coming months, despite a projected increase in COVID-19 rates
Receiving Social Security benefits on someone else’s earnings record.
3 client questions every adviser should anticipate as firms emerge from the shutdown
A bipartisan bill to amend the Internal Revenue Code hints at more attention to the issue, according to a report from Morningstar
The ruling came in a lawsuit brought by a California couple ordered to pay $27 million after being found to have defrauded investors
There's more to the so-called free trades than meets the eye
The guidance allows more people to withdraw funds penalty-free from their retirement savings
Digital advice players have long heralded low-cost investing, but firms are offering differentiated strategies
The increase in delinquences in May was smaller than the jump in April, as the economy ground to a halt
The dispute between Attorney General Barr and Geoffrey Berman has cast a shadow over Clayton's nomination for the position
U.S. regulators dropped the ball in a recent letter clarifying that regulations do not prohibit the use of private equity funds in 401(k) plans
Massive stimulus efforts may not be enough to overcome the challenges posed by high unemployment, damage to small businesses
Experts debate the effects of the stimulus spending and Fed rescue efforts on the future of the economy
Jay Clayton would replace Geoffrey Berman, who is exiting after 2½ years in the job
The architect of the DOL fiduciary rule remains skeptical of the SEC measure
Only 15% of participants in the survey said they received messages through mobile apps at the beginning of the COVID-19 crisis
The Texas couple made 90 unauthorized distributions from pension and retirement plans they ran
The Democratic choice is likely to be paired with Republican Hester Peirce in the confirmation process
The fund's biggest holding is Moderna, whose stock price has more than tripled this year on news about vaccine it's developing
